NNBR:NASDAQNN, Inc. Analysis
Data as of 2026-08-25 - not real-time
$3.62
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind NN, Inc. is bullish at $3.62, with short-term averages leading the long-term ones. It has gained 5.8% over the past 30 days. RSI sits at 49.8, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $3.05 up to resistance at $4.48.
The shares look undervalued, trading on 19.1 times earnings below a sector average of 29.7. Analyst price targets sit 84.2% above the current price. Revenue is growing at 19.3% on a -6.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 79.1%, a beta of 1.94 and a maximum drawdown of 56.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.
The shares look undervalued, trading on 19.1 times earnings below a sector average of 29.7. Analyst price targets sit 84.2% above the current price. Revenue is growing at 19.3% on a -6.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 79.1%, a beta of 1.94 and a maximum drawdown of 56.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.
Top Market Events
CHARLOTTE, N.C. AP — CHARLOTTE, N.C. AP — NN Inc. NNBR on Wednesday reported a loss of $2.3 million in its second...Industrial components supplier NN NASDAQ:NNBR reported Q2 CY2026 results beating Wall Street’s revenue expectations,...Transaction reduces approximately $89 Million of Series D preferred stock, materially deleverages CompanyCHARLOTTE, N.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 2.17
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 19.1 versus sector average of 29.7
- Trading above the 200-day average of 2.17
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 19.1 versus sector average of 29.7
- Negative profit margin of -6.2%
- Analyst targets imply +84.2% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth19.30%
Profit Margin-6.21%
P/E Ratio19.1
ROE-18.35%
ROA-1.77%
Debt/Equity149.85
P/B Ratio9.0
Op. Cash Flow$21.5M
Free Cash Flow$19.1M
Industry P/E29.7
Technical Analysis
TrendBullish
RSI49.8
Support$3.05
Resistance$4.48
MA 20$3.69
MA 50$3.44
MA 200$2.17
MACDBearish
VolumeDecreasing
Fear & Greed Index93.2
Valuation
Fair Value$4.05
Target Price$6.67
Upside/Downside84.16%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.94
Volatility79.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.